Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Ring finger and CCCH-type domains 2 (RC3H2), also known as Roquin-2, is a highly conserved multi-domain protein. It features a RING finger domain conferring E3 ubiquitin ligase activity and a CCCH-type zinc finger domain that, together with a unique ROQ domain, mediates specific RNA binding. RC3H2 binds to conserved stem-loop motifs (constitutive decay elements or CDEs) in target mRNA 3'-untranslated regions, promoting deadenylation and degradation of these transcripts in a miRNA-independent manner. It plays a critical role in immune regulation by repressing the expression of key genes involved in T cell activation and inflammation (such as ICOS, TNFRSF4, TNF, and NFKBID), thus maintaining immunological self-tolerance and preventing hyperinflammatory states. RC3H2 acts as an E3 ubiquitin ligase, interacting with several E2 enzymes to assemble polyubiquitin chains and regulate substrate turnover. Dysfunction of RC3H2 or its paralog Roquin-1 is associated with autoimmunity, chronic inflammation, and potentially tumorigenesis. No clinically approved drugs are known to directly target RC3H2 as of the current knowledge. However, its central role in post-transcriptional gene regulation and immune homeostasis make it of interest as a potential therapeutic target for immune-related and inflammatory diseases.
Small molecules or biologics (in theory) that modulate RNA binding or E3 ligase activity could alter mRNA degradation pathways or immune responses
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Ring finger and CCCH-type domains 2 (RC3H2).